• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides.

作者信息

Frenkel D, Clark D E, Li J, Murray C W, RObson B, Waszkowycz B, Westhead D R

机构信息

Proteus Molecular Design Ltd., Macclesfield, Cheshire, U.K.

出版信息

J Comput Aided Mol Des. 1995 Jun;9(3):213-25. doi: 10.1007/BF00124453.

DOI:10.1007/BF00124453
PMID:7561974
Abstract

In some instances, peptides can play an important role in the discovery of lead compounds. This paper describes the peptide design facility of the de novo drug design package, PRO_LIGAND. The package provides a unified framework for the design of peptides that are similar or complementary to a specified target. The approach uses single amino acid residues, selected from preconstructed libraries of different residues and conformations, and places them on top of predefined target interaction sites. This approach is a well-tested methodology for the design of organics but has not been used for peptides before. Peptides represent a difficulty because of their great conformational flexibility and a study of the advantages and disadvantages of this simple approach is an important step in the development of design tools. After a description of our general approach, a more detailed discussion of its adaptation to peptides is given. The method is then applied to the design of peptide-based inhibitors to HIV-1 protease and the design of structural mimics of the surface region of lysozyme. The results are encouraging and point the way towards further development of interaction site-based approaches for peptide design.

摘要

相似文献

1
PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides.
J Comput Aided Mol Des. 1995 Jun;9(3):213-25. doi: 10.1007/BF00124453.
2
PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
J Comput Aided Mol Des. 1995 Oct;9(5):381-95. doi: 10.1007/BF00123996.
3
Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.人免疫缺陷病毒1型蛋白酶紧密结合抑制剂的设计
Methods Enzymol. 1994;241:311-34. doi: 10.1016/0076-6879(94)41071-2.
4
Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease.基于对称性的人免疫缺陷病毒蛋白酶拟肽抑制剂的设计。
Methods Enzymol. 1994;241:334-54. doi: 10.1016/0076-6879(94)41072-0.
5
Protein promiscuity: drug resistance and native functions--HIV-1 case.蛋白质的多特异性:耐药性与天然功能——以HIV-1为例
J Biomol Struct Dyn. 2005 Jun;22(6):615-24. doi: 10.1080/07391102.2005.10531228.
6
Advances in automated docking applied to human immunodeficiency virus type 1 protease.应用于1型人类免疫缺陷病毒蛋白酶的自动对接技术进展。
Methods Enzymol. 1994;241:354-70. doi: 10.1016/0076-6879(94)41073-9.
7
PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules.前体配体:一种从头开始的分子设计方法。1. 应用于有机分子设计
J Comput Aided Mol Des. 1995 Feb;9(1):13-32. doi: 10.1007/BF00117275.
8
The role of structure in antibody cross-reactivity between peptides and folded proteins.结构在肽与折叠蛋白之间抗体交叉反应中的作用。
J Mol Biol. 1998 Aug 7;281(1):183-201. doi: 10.1006/jmbi.1998.1907.
9
Empirical free energy as a target function in docking and design: application to HIV-1 protease inhibitors.
FEBS Lett. 1996 Apr 8;384(1):87-91. doi: 10.1016/0014-5793(96)00276-1.
10
A modular approach to HIV-1 proteinase inhibitor design.一种用于HIV-1蛋白酶抑制剂设计的模块化方法。
Biochem Biophys Res Commun. 1996 May 6;222(1):38-43. doi: 10.1006/bbrc.1996.0694.

引用本文的文献

1
Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design.肽对病毒膜融合的抑制作用及肽设计方法
Pathogens. 2021 Dec 9;10(12):1599. doi: 10.3390/pathogens10121599.
2
Methods for Molecular Modelling of Protein Complexes.蛋白质复合物的分子建模方法。
Methods Mol Biol. 2021;2305:53-80. doi: 10.1007/978-1-0716-1406-8_3.
3
Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein.辅助肽疫苗和拟肽设计的技术。SARS-CoV-2 刺突糖蛋白中的侧链暴露。

本文引用的文献

1
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.比较分子场分析(CoMFA)。1. 形状对类固醇与载体蛋白结合的影响。
J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005.
2
Stereochemistry of polypeptide chain configurations.多肽链构型的立体化学
J Mol Biol. 1963 Jul;7:95-9. doi: 10.1016/s0022-2836(63)80023-6.
3
GroupBuild: a fragment-based method for de novo drug design.GroupBuild:一种用于从头药物设计的基于片段的方法。
Comput Biol Med. 2021 Jan;128:104124. doi: 10.1016/j.compbiomed.2020.104124. Epub 2020 Nov 21.
4
COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.用于合成疫苗、肽模拟拮抗剂和治疗性药物的 COVID-19 冠状病毒刺突蛋白分析,以及对保守区域阿喀琉斯之踵的分析,以最大程度地降低逃逸突变和耐药性的可能性。
Comput Biol Med. 2020 Jun;121:103749. doi: 10.1016/j.compbiomed.2020.103749. Epub 2020 Apr 11.
5
VitAL: Viterbi algorithm for de novo peptide design.VitAL:从头设计肽的维特比算法。
PLoS One. 2010 Jun 2;5(6):e10926. doi: 10.1371/journal.pone.0010926.
6
ENPDA: an evolutionary structure-based de novo peptide design algorithm.ENPDA:一种基于进化结构的从头肽设计算法。
J Comput Aided Mol Des. 2005 Aug;19(8):585-601. doi: 10.1007/s10822-005-9015-1. Epub 2005 Nov 3.
7
PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology.PRO_SELECT:结合基于结构的药物设计和组合化学以快速发现先导化合物。1. 技术
J Comput Aided Mol Des. 1997 Mar;11(2):193-207. doi: 10.1023/a:1008094712424.
8
Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.迈向合成可及性蛋白质配体的自动化设计:肽、酰胺和拟肽
J Comput Aided Mol Des. 1996 Aug;10(4):265-72. doi: 10.1007/BF00124496.
9
PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
J Comput Aided Mol Des. 1995 Oct;9(5):381-95. doi: 10.1007/BF00123996.
J Med Chem. 1993 Jun 11;36(12):1700-10. doi: 10.1021/jm00064a003.
4
GenStar: a method for de novo drug design.GenStar:一种全新药物设计方法。
J Comput Aided Mol Des. 1993 Feb;7(1):23-43. doi: 10.1007/BF00141573.
5
Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.
J Med Chem. 1993 Oct 1;36(20):2921-8. doi: 10.1021/jm00072a011.
6
Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase.结合位点中配体的多拷贝同时搜索与构建:应用于HIV-1天冬氨酸蛋白酶抑制剂
J Med Chem. 1993 Jul 23;36(15):2142-67. doi: 10.1021/jm00067a013.
7
SPROUT: a program for structure generation.
J Comput Aided Mol Des. 1993 Apr;7(2):127-53. doi: 10.1007/BF00126441.
8
Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.人类免疫缺陷病毒(I)蛋白酶抑制剂的三维定量构效关系。1. 一项采用实验确定的比对规则的比较分子场分析研究。
J Med Chem. 1993 Dec 24;36(26):4152-60. doi: 10.1021/jm00078a003.
9
The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.NEWLEAD 程序:一种基于药效团假设设计候选结构的新方法。
J Med Chem. 1993 Nov 26;36(24):3863-70. doi: 10.1021/jm00076a016.
10
Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.组合技术在药物发现中的应用。1. 背景与肽组合文库
J Med Chem. 1994 Apr 29;37(9):1233-51. doi: 10.1021/jm00035a001.